Please provide your email address to receive an email when new articles are posted on . Age, nulliparity, polyps and shorter sampling intervals may predict endometrial hyperplasia and cancer. Risk ...

Several studies have investigated the mechanisms involved in progestin resistance. Decreased availability of progestin receptors before treatment or alterations in progestin receptor regulatory ...

Please provide your email address to receive an email when new articles are posted on . Conjugated estrogen/bazedoxifene users had higher endometrial cancer and endometrial hyperplasia rates vs.

Although it might seem reasonable to pronounce women cured after their endometrial hyperplasia regresses from hormonal treatment, researchers caution that long-term monitoring for relapse and cancer ...

Use of Metformin -- commonly used as the front-line treatment for type 2 diabetes -- improves survival for some breast cancer patients, and shows promise as a treatment for patients diagnosed with ...

Conservative treatment solely with a levonorgestrel-releasing intrauterine device (IUD) led to a 75% response rate for complex atypical hyperplasia and endometrial cancer in a small cohort of low-risk ...

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2 We conducted a case ...

Hormonal therapy with an intrauterine device (IUD) led to complete tumor regression in two-thirds of women with early-stage endometrial cancer or precancerous lesions, a randomized pragmatic phase II ...

Endometrial cancer is the most common form of cancer of the female reproductive organs in the U.S., with 67,880 new cases diagnosed each year. Over the past decades, rates have increased and ...